Pluschnig, Ursula <br/><br/>
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma.  [electronic resource] 

 -  Anticancer research  Mar 2013 
 - 1035-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Capecitabine<br/>Deoxycytidine--administration & dosage<br/>Epirubicin--administration & dosage<br/>Esophagogastric Junction<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Liver Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Palliative Care<br/>Stomach Neoplasms--drug therapy